L-asparaginases from bacterial sources have been used in antineoplastic treatments and the food industry. A type II L-asparaginase encoded by the N-truncated gene ansZP21 of halotolerant Bacillus subtilis CH11 isolated from Chilca salterns in Peru was expressed using a heterologous system in Escherichia coli BL21 (DE3)pLysS. The recombinant protein was purified using one-step nickel affinity chromatography and exhibited an activity of 234.38 U mg−1 and a maximum catalytic activity at pH 9.0 and 60 °C. The enzyme showed a homotetrameric form with an estimated molecular weight of 155 kDa through gel filtration chromatography. The enzyme half-life at 60 °C was 3 h 48 min, and L-asparaginase retained 50% of its initial activity for 24 h at 37 °C. The activity was considerably enhanced by KCl, CaCl2, MgCl2, mercaptoethanol, and DL-dithiothreitol (p-value < 0.01). Moreover, the Vmax and Km were 145.2 µmol mL−1 min−1 and 4.75 mM, respectively. These findings evidence a promising novel type II L-asparaginase for future industrial applications.
L-asparaginase from bacterial sources have been used in antineoplastic treatments and the food industry. A novel type II L-a sparaginase encoded by the N-truncated gene ansZP21 of halotolerant Bacillus subtilis CH11 isolated from Chilca salterns in Peru was expressed using a heterologous system in Escherichia coli BL21 (DE3)pLysS. The recombinant protein was purified using one-step nickel affinity chromatography and exhibited activity of 234.38 U mg-1 and a maximum catalytic activity at pH 9.0 and 60 °C. The enzyme shows a homotetrameric form with an estimated molecular weight of 155 kDa by gel filtration chromatography. The enzyme half-life at 60 °C was 3 h 48 min, and L-asparaginase retained 50% of initial activity for 24 h at 37 °C. The activity was considerably enhanced by KCl, CaCl2, MgCl2, mercaptoethanol, and DL-dithiothreitol (p-value < 0.01). Moreover, the Vmax and Km were 145.2 µmol mL-1 min-1 and 4.752 mM, respectively. These findings evidence a promising novel type II L-asparaginase for future industrial applications.
Emergence of antimicrobial resistance is a pressing global issue. Although myriads of mechanisms for survival against antimicrobial pressure have surfaced, one key strategy is the structural modification of peptidoglycan, the main defense line in Gram-positive bacteria e.g., notorious pathogen Staphylococcus aureus . Here we show that the recently identified peptidoglycan hydrolase (PGH) LytU is an unusual catalyst in the lysostaphin (M23B) family of zinc-endopeptidases that hydrolyze the glycyl-glycine peptide bond in S. aureus . Unlike any other PGH recognized thus far, LytU hydrolyzes the isopeptide bond between the lysine ε amino group and pentaglycine, thus functioning as a bridge-link hydrolase. We discovered that LytM and LytU are functionally non-redundant, and they contribute to the cell wall remodeling at different stages of PG maturation. Additionally, we demonstrate that LytU particularly targets the PG precursor, pGly-Lipid II, and its overexpression leads to growth inhibition and a less densely cross-linked cell wall, which increases susceptibility to lysostaphin. Interestingly, LytU expression enhances resistance to the glycopeptide vancomycin, the drug of last resort against S. aureus .